AzTrials
AzTrials

Cardiac Arrest, SuddenNCT04485390

Impact of the Organization of the First Responders in the Remote Areas on Cardiac Arrest Victim Survival

An observational study of Cardiac Arrest, Sudden, run by University Medical Centre Maribor.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Emergency medical services (EMS) provide emergency care not only in the urban but also in the remote areas which could be up to 40 minutes from the EMS station. Thus, a cardiac arrest victim in those remote areas has a low likelihood to survive the cardiopulmonary resuscitation. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cardiac Arrest, Sudden
What is being tested?
Basic life support witn use of an AED before EMS
How many people
150 participants
Where
No sites listed yet
Study dates
1 Mar 2014to 31 Aug 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: In the study will be included all adult cardiac arrest victims in the remote areas.

Who may be able to join

  • cardiac arrest in adult victims

Who cannot join

  • cardiac arrest in pediatric population

About this study

Official title: Impact of the Organization of the First Responders in the Remote Areas on Cardiac Arrest Victim Survival: an Utstein Analysis

Emergency medical services (EMS) provide emergency care not only in the urban but also in the remote areas which could be up to 40 minutes from the EMS station. Thus, a cardiac arrest victim in those remote areas has a low likelihood to survive the cardiopulmonary resuscitation. Therefore, we have organized first responders (who are mostly volunteer fire-fighters) in the remote areas and taught them how to perform basic life support (BLS) with use of an automated external defibrillator (AED). In the case of a cardiac arrest the medical dispatcher activates simultaneously the EMS and the first responders, who perform the BLS with the use of an AED before the arrival of EMS.

The aim of the study is to analyze and compare the survival of the cardiac arrest victims in remote areas in the time period when the first responders were not organized yet compared to the time period when the first responders were activated to perform BLS.

Being tested
Basic life support witn use of an AED before EMS
Keywords
cardiac arrest, cardiopulmonary resuscitation, automated external defibrillator, first responders
Medical subject headings
Death, Sudden, Cardiac, Heart Arrest

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Basic life support witn use of an AED before EMSOther

    BLS performance with use of an AED before arrival of EMS

Study groups in NCT04485390
Study groupRoleWhat they receive
First responder groupCardiac arrest victims in remote areas resuscitated by the first responders before the arrival of the EMS.
Receives: Other: Basic life support witn use of an AED before EMS
EMS groupsCardiac arrest victims in remote areas resuscitated by the EMS.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Return of spontaneous circulation (ROSC)

    The number of patients who gained the ROSC.

    Measured: 5 years

  2. Survival to hospital discharge

    The number of patients who survived to hospital discharge.

    Measured: 5 years

  3. Neurological outcome

    The number of patients with good neurological outcome assessed with cerebral performance score (CPC 1-2).

    Measured: 5 years

Secondary outcomes (2)
  1. Survival till hospital admission

    The number of patients who survived to hospital admission.

    Measured: 5 years

  2. 30 day survival

    The number of patients who survived first 30 days after cardiac arrest.

    Measured: 5 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jul 2020
  2. Study start1 Mar 2014
  3. Primary completion31 Dec 2019
  4. Study completion31 Aug 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
150 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04485390
Sponsor's protocol ID
UKC-MB-KME-24/20
Status last verified
Sep 2021
First submitted
21 Jul 2020
Last updated
5 Oct 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Cardiac Arrest, Sudden, run by University Medical Centre Maribor.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Return of spontaneous circulation (ROSC) (time frame: 5 years). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Oct 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in